Recent Security Class Actions

Fractyl Health Inc. Common Stock (NASDAQ: GUTS)

44 Days left to seek lead plaintiff status.

Company Name:Fractyl Health Inc. Common Stock
Stock Symbol:NASDAQ: GUTS
Class Period Start:01/13/2025
Class Period End (inclusive):01/29/2026
Filing Deadline:10/20/2026

The complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operations, and prospects. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) Revita was less effective than Defendants had led investors to believe, and/or operational issues at one or more of the REMAIN-1 Midpoint Cohort’s clinical sites compromised the integrity of its efficacy results; (ii) accordingly, Revita’s clinical, regulatory, and commercial prospects were overstated, as was the REMAIN-1 Midpoint Cohort’s ability to assess Revita’s efficacy; and (iii) as a result, Defendants’ public statements were materially false and misleading at all relevant times. Fractyl’s stock price fell $1.245 per share, or 68.03%, to close at $0.585 per share on January 29, 2026.

Fractyl Health Inc. Common Stock (NASDAQ: GUTS) Claim Form

This field is for validation purposes and should be left unchanged.
Name(Required)
Address